PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9585152-5 1998 Azelastine inhibited TNF-alpha release at concentrations lower than those needed for the inhibition of degranulation. azelastine 0-10 tumor necrosis factor Rattus norvegicus 21-30 15806111-1 2005 1 To clarify the mechanism of mast cell TNF secretion, especially its release process after being produced, we utilized an antiallergic drug, azelastine (4-(p-chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)- phthalazinone), which has been reported to inhibit TNF release without affecting its production in ionomycin-stimulated RBL-2H3 cells. azelastine 142-152 tumor necrosis factor Rattus norvegicus 40-43 15806111-1 2005 1 To clarify the mechanism of mast cell TNF secretion, especially its release process after being produced, we utilized an antiallergic drug, azelastine (4-(p-chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)- phthalazinone), which has been reported to inhibit TNF release without affecting its production in ionomycin-stimulated RBL-2H3 cells. azelastine 142-152 tumor necrosis factor Rattus norvegicus 270-273 15806111-1 2005 1 To clarify the mechanism of mast cell TNF secretion, especially its release process after being produced, we utilized an antiallergic drug, azelastine (4-(p-chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)- phthalazinone), which has been reported to inhibit TNF release without affecting its production in ionomycin-stimulated RBL-2H3 cells. azelastine 154-232 tumor necrosis factor Rattus norvegicus 40-43 15806111-1 2005 1 To clarify the mechanism of mast cell TNF secretion, especially its release process after being produced, we utilized an antiallergic drug, azelastine (4-(p-chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)- phthalazinone), which has been reported to inhibit TNF release without affecting its production in ionomycin-stimulated RBL-2H3 cells. azelastine 154-232 tumor necrosis factor Rattus norvegicus 270-273 9585152-4 1998 We compared the effects of azelastine, an anti-allergic drug, on TNF-alpha secretion, on Ca2+ signal, and on degranulation in an antigen- or ionomycin-stimulated rat mast RBL-2H3 cell line. azelastine 27-37 tumor necrosis factor Rattus norvegicus 65-74 15806111-9 2005 6 These results suggest that (alpha)PKC mediates the TNF release process and azelastine inhibits TNF release by selectively interfering with the recruitment of (alpha)PKC in the pathway activated by ionomycin in RBL-2H3 cells. azelastine 77-87 tumor necrosis factor Rattus norvegicus 97-100 9585152-6 1998 In antigen-stimulated cells, azelastine also inhibited equipotently TNF-alpha mRNA expression/protein synthesis, TNF-alpha release and Ca2+ influx. azelastine 29-39 tumor necrosis factor Rattus norvegicus 68-77 9585152-6 1998 In antigen-stimulated cells, azelastine also inhibited equipotently TNF-alpha mRNA expression/protein synthesis, TNF-alpha release and Ca2+ influx. azelastine 29-39 tumor necrosis factor Rattus norvegicus 113-122 9585152-7 1998 In ionomycin-stimulated cells, however, azelastine inhibited TNF-alpha release to a greater extent than TNF-alpha mRNA expression/protein synthesis and Ca2+ influx, indicating that azelastine inhibits the release process more potently than transcription or production of TNF-alpha by interfering with a signal other than Ca2+. azelastine 40-50 tumor necrosis factor Rattus norvegicus 61-70 9300717-0 1997 Suppression of TNF-alpha secretion by azelastine in a rat mast (RBL-2H3) cell line: evidence for differential regulation of TNF-alpha release, transcription, and degranulation. azelastine 38-48 tumor necrosis factor Rattus norvegicus 15-24 9300717-4 1997 In a rat mast RBL-2H3 cell line, azelastine inhibited Ag- and ionomycin-induced TNF-alpha release with IC50 values of 25.7 +/- 3.4 microM and 1.66 +/- 0.45 microM, respectively. azelastine 33-43 tumor necrosis factor Rattus norvegicus 80-89 9300717-6 1997 In Ag-stimulated cells, azelastine also inhibited TNF-alpha mRNA expression, TNF-alpha protein synthesis and release, and, possibly related to these effects, Ca2+ influx. azelastine 24-34 tumor necrosis factor Rattus norvegicus 50-59 9300717-6 1997 In Ag-stimulated cells, azelastine also inhibited TNF-alpha mRNA expression, TNF-alpha protein synthesis and release, and, possibly related to these effects, Ca2+ influx. azelastine 24-34 tumor necrosis factor Rattus norvegicus 77-86 9300717-7 1997 In ionomycin-stimulated cells, however, azelastine inhibited TNF-alpha release to a greater extent than mRNA expression/protein synthesis and Ca2+ influx, suggesting that azelastine inhibits the release process more potently than transcription or production of TNF-alpha by interfering with a signal other than Ca2+. azelastine 40-50 tumor necrosis factor Rattus norvegicus 61-70 9300717-8 1997 Azelastine added 1 h after ionomycin stimulation also immediately blocked subsequent release of TNF-alpha, which had been produced in the cells, without affecting Ca2+ influx. azelastine 0-10 tumor necrosis factor Rattus norvegicus 96-105